• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, Augu

tetano

Editor, Senior Moderator
Eurosurveillance, Volume 22, Issue 11, 16 March 2017
Surveillance and outbreak report

Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016


M Ali [SUP]1[/SUP] , R El-Shesheny [SUP]1[/SUP] , A Kandeil [SUP]1[/SUP] , M Shehata [SUP]1[/SUP] , B Elsokary [SUP]2[/SUP] , M Gomaa [SUP]1[/SUP] , N Hassan [SUP]2[/SUP] , A El Sayed [SUP]1[/SUP] , A El-Taweel [SUP]1[/SUP] , H Sobhy [SUP]3[/SUP] , FF Oludayo [SUP]6[/SUP] , G Dauphin [SUP]5[/SUP] , I El Masry [SUP]3[/SUP] , AW Wolde [SUP]3[/SUP] , P Daszak [SUP]4[/SUP] , M Miller [SUP]4[/SUP] , S VonDobschuetz [SUP]5[/SUP] , E Gardner [SUP]5[/SUP] , S Morzaria [SUP]5[/SUP] , J Lubroth [SUP]5[/SUP] , YJ Makonnen [SUP]3[/SUP]
+ Author affiliations
1. National Research Center, Division of Environmental Research, Giza, Egypt
2. General Organizations of Veterinary Services, Ministry of Agriculture and Land reclamation (MoALR), Giza, Egypt
3. Food and Agriculture Organization of the United Nations, Emergency Center for Transboundary Animal Diseases (ECTAD), Egypt
4. EcoHealth Alliance, New York, New York, United States
5. Food and Agriculture Organization of the United Nations, Rome, Italy
6. Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, South Africa


Correspondence: Mohamed Ahmed Ali (mohamedahmedali2004@yahoo.com)








Citation style for this article: Ali M, El-Shesheny R, Kandeil A, Shehata M, Elsokary B, Gomaa M, Hassan N, El Sayed A, El-Taweel A, Sobhy H, Oludayo FF, Dauphin G, El Masry I, Wolde AW, Daszak P, Miller M, VonDobschuetz S, Gardner E, Morzaria S, Lubroth J, Makonnen YJ. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill. 2017;22(11):pii=30487. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2017.22.11.30487

Received:10 April 2016; Accepted:05 October 2016

[h=4][/h]
A cross-sectional study was conducted in Egypt to determine the prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in imported and resident camels and bats, as well as to assess possible transmission of the virus to domestic ruminants and equines. A total of 1,031 sera, 1,078 nasal swabs, 13 rectal swabs, and 38 milk samples were collected from 1,078 camels in different types of sites. In addition, 145 domestic animals and 109 bats were sampled. Overall, of 1,031 serologically-tested camels, 871 (84.5%) had MERS-CoV neutralising antibodies. Seroprevalence was significantly higher in imported (614/692; 88.7%) than resident camels (257/339; 5.8%) (p < 0.05). Camels from Sudan (543/594; 91.4%) had a higher seroprevalence than those from East Africa (71/98; 72.4%) (p < 0.05). Sampling site and age were also associated with MERS-CoV seroprevalence (p < 0.05). All tested samples from domestic animals and bats were negative for MERS-CoV antibodies except one sheep sample which showed a 1:640 titre. Of 1,078 camels, 41 (3.8%) were positive for MERS-CoV genetic material. Sequences obtained were not found to cluster with clade A or B MERS-CoV sequences and were genetically diverse. The presence of neutralising antibodies in one sheep apparently in contact with seropositive camels calls for further studies on domestic animals in contact with camels.

full article

http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22743
 
Back
Top